Trial Profile
Comparative effect of second-generation antipsychotic blonanserin and aripiprazole on cognitive impairment in first-episode schizophrenia: An open-label trial
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Blonanserin (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 19 May 2014 Results published in the Psychiatry and Clinical Neurosciences.
- 19 Jun 2013 New trial record